SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: epicure who wrote (850)5/7/1998 12:08:00 PM
From: KM  Read Replies (1) | Respond to of 2135
 
Also keep an eye on Techniclone (TCLN), Ribozyme (RZYM) and Auguron (sp?). All in the same race, some further ahead.



To: epicure who wrote (850)5/7/1998 4:16:00 PM
From: Big Brother  Read Replies (3) | Respond to of 2135
 
>>ENMD is sort of the anti- KTEL in terms of their press releases. I must say that the
management has acted very ethically in trying not to mislead anyone.<<

Perhaps. But why did this happen in the first place? And how?

I'll reserve my "ethics" opinion.

BB


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News